Shigeki Chiba

2.1k citations
34 papers · 1.7k indexed · 1 hit paper · h-index 16
Topics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers)Immunotherapy and Immune Responses (3 papers)Cancer Genomics and Diagnostics (3 papers)
Partner nations
JapanUnited StatesRussia

In The Last Decade

Shigeki Chiba

32 papers receiving 1.6k citations

Hit Papers

Tumor-infiltrating DCs suppress nucleic acid–mediated inn...20122026201620212012200400600

Peers

Shigeki Chiba
Comparison fields: 5 of 106
  • Immunology 925
  • Oncology 708
  • Molecular Biology 495
  • Pulmonary and Respiratory Medicine 242
  • Cancer Research 189
Replace Jong‐Baeck Lim with:
Jong‐Baeck Lim South Korea
Tsvetelina Pentcheva‐Hoang United States
A. Sloëtjes Netherlands
Rosa A. Sierra United States
Zhu‐Xu Zhang Canada
Ladislav Burýšek Czechia
Ernst Peter Rieber Germany
Alyssa D. Gregory United States
Annie L’Helgoualc’h France
Véronique Mateo France
Shigeki Chiba relative to Jong‐Baeck Lim South Korea Jong‐Baeck Lim's profile →
Citations per field
00.5×1.5×2.2×
Jong‐Baeck Lim · 1×
Citations per year

Countries citing papers authored by Shigeki Chiba

Since Specialization
Citations

This map shows the geographic impact of Shigeki Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeki Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeki Chiba more than expected).

Fields of papers citing papers by Shigeki Chiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeki Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeki Chiba. The network helps show where Shigeki Chiba may publish in the future.

Co-authorship network of co-authors of Shigeki Chiba

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeki Chiba. A scholar is included among the top collaborators of Shigeki Chiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeki Chiba. Shigeki Chiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 9
3 9
4 110
5 10
6 12
7 18
8
Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1breakdown →
669
9 24
10 23
11 15
12 28
13 35
14 16
15 1
16 9
17 18
18 4
19 8
20 18

About Shigeki Chiba

Shigeki Chiba is a scholar working on Gastroenterology, Immunology and Cancer Research, having authored 34 papers that have together received 1.7k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Immunotherapy and Immune Responses (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Immunology (925 citations), Oncology (708 citations) and Cancer Research (189 citations). Shigeki Chiba has collaborated with scholars based in Japan, United States and Russia. Frequent co-authors include Masahisa Jinushi, Hironori Yoshiyama, Akinori Takaoka, Hirotoshi Dosaka‐Akita, Ichiro Kinoshita, Hideo Yagita∥, Muhammad Baghdadi, Toshimitsu Uede, Yoichiro Fujioka and Yusuke Ohba. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026